Skip to main content

Table 4 Publication bias

From: Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis

Outcomes

P value for Egger

P value for Begg

Resectability

0.363

0.711

OS

0.763

1.000

PFS

0.444

1.000

1-year survival rate

0.376

0.764

2-year survival rate

0.266

1.000

3-year survival rate

0.991

0.806

4-year survival rate

0.065

0.221

5-year survival rate

0.009

0.452

1-year recurrence

0.069

1.000

2-year recurrence

0.242

0.296

3-year recurrence

0.243

0.296

4-year recurrence

0.723

1.000

5-year recurrence

0.887

1.000